Duloxetine Treatment in Elderly With Dysthymia

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

March 31, 2013

Conditions
DepressionDysthymic Disorder
Interventions
DRUG

Duloxetine

"Patients were evaluated weekly for the first 6 weeks and every two weeks for the next 6 weeks. At 0, 1, 4, 8, and 12 weeks, the study psychiatrist completed the Cornell Dysthymia Rating Scale , Clinical Global Impression (CGI) scale, and side effect ratings using the Treatment Emergent Symptom Scale. The research rater completed a SCID-P at baseline and the 24-item HAM-D at each visit, and the patient completed the Beck Depression Inventory-II at each visit.~Adverse events: All adverse events and serious adverse events were documented.~The maximum duration of delay before active treatment (medication or psychotherapy) was 1 week.~Dropout: Patients who had a CGI score of 6 or 7 for two weeks during the second half of the study were dropped by the investigator from the trial."

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

New York State Psychiatric Institute

OTHER

NCT01852383 - Duloxetine Treatment in Elderly With Dysthymia | Biotech Hunter | Biotech Hunter